Latest Share Chat

Avacta Group Share News (AVCT)

Avacta Group Information

Buy AVCT Shares
Add AVCT to Watchlist
Add AVCT to Alert

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 46.50

Bid: 46.00

Ask: 47.00

Change: 0.75 (1.64%)

Spread: 1.00 (2.174%)

Open: 45.75

High: 48.50

Low: 45.75

Prev. Close: 45.75

Last checked at -

IN BRIEF: Avacta to sell Covid-19 test in UK in "coming days"

Mon, 10th May 2021 11:13

Avacta Group PLC - Yorkshire-based drug and diagnostic equipment developer - Submits declaration of conformity for rapid Covid-19 lateral flow test to the UK's Medicines & Healthcare Products Regulatory Agency. Expects registration of test to be confirmed in the coming days, before it is immediately placed on the market. The test has been shown to be more sensitive than lateral flow tests currently on the market, particularly for lower viral loads.

Current stock price: 266.88 pence, up 1.9% on Monday

Year-to-date change: more than doubled from 114.0p on December 31

By Ivan Edwards; ivanedwards@alliancenews.com

More News

4 Jun 2020 14:31

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

4 Jun 2020 09:27

Avacta raising £45m to fund diagnostics and therapies pipeline

(Sharecast News) - Biotherapeutic and reagent developer Avacta Group announced its intention to raise up to £45m through a placing to institutional and other investors, a direct subscription with the company, and offers to retail and other investors via the PrimaryBid platform, it announced on Thursday.

20 May 2020 10:16

Avacta signs Covid-19 test distribution deal with Boohoo founders

(Sharecast News) - Avacta Group has entered into an exclusive distribution agreement with Medusa19 for direct-to-consumer sales of a saliva-based rapid test for the Covid-19 antigen, it announced on Wednesday.

11 May 2020 12:03

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

11 May 2020 08:43

Avacta Group ships Covid-19 testing reagents

(Sharecast News) - Biotherapeutics developer Avacta Group shipped out reagents for Covid-19 antigen testing to its diagnostic test development partners on Monday.

6 May 2020 17:18

Avacta Group Reports Widened Loss Amid Higher Operating Expenses

1 May 2020 13:28

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

1 May 2020 13:17

Avacta to collaborate with Adeptrix on Covid-19 tests

(Sharecast News) - Biotherapeutics developer Avacta has entered into a collaboration agreement with American firm Adeptrix to develop a high throughput Covid-19 antigen test using its proprietary bead-assisted mass spectrometry (BAMS) platform.

29 Apr 2020 16:13

UK Earnings, Trading Statements Calendar - Next 7 Days

22 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order

22 Apr 2020 14:50

Avacta shares surge on progress with Covid test

(Sharecast News) - Avacta Group said on Wednesday that, in four weeks and "well ahead" of schedule, it had successfully generated multiple 'Affimer' reagents that bound the SARS-COV-2 viral antigen as part of the collaboration with Cytiva - formerly GE Healthcare Life Sciences - to develop an Affimer-based rapid test for the Covid-19 coronavirus infection.

14 Apr 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

8 Apr 2020 10:41

Avacta To Co-Develop Test That Can Diagnose Covid-19 In Minutes

7 Apr 2020 07:31

Avacta Raises More-Than-Expected GBP3.8 Million In Share Placing

6 Apr 2020 12:42

Avacta raises ?3.75m, expects minimal impact from pandemic

(Sharecast News) - Biotherapeutics company Avacta Group announced on Monday that, in response to "substantial" institutional interest, it has conditionally raised gross proceeds of ?3.75m under a placing, through the issue of 20,833,333 new ordinary shares at a price of 18p each.

Latest Share Chat

Avacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Avacta to sell Covid-19 test in UK in "coming days"

Login to your account

Quickpicks are a member only feature

Login to your account